1. |
Vijayakumar B, Elango P, Ganessan R. Post-operative delirium in elderly patients. Indian J Anaesth, 2014, 58(3): 251-256.
|
2. |
Trull T J, Verges A, Wood P K, et al. The structure of Diagnostic And Statistical Manual of Mental Disorders (4th edition, text revision) personality disorder symptoms in a large national sample. Personal Disord, 2012, 3(4): 355-369.
|
3. |
Jackson T A, Wilson D, Richardson S, et al. Predicting outcome in older hospital patients with delirium: a systematic literature review. Int J Geriatr Psychiatry, 2016, 31(4): 392-399.
|
4. |
Ma Lina, Zhang Ruili. Risk, diagnosis and treatment to postoperative delirium in elderly patients with gastrointestinal cancers. Hepatogastroenterology, 2015, 62(138): 529-535.
|
5. |
Androsova G, Krause R, Winterer G, et al. Biomarkers of postoperative delirium and cognitive dysfunction. Front Aging Neurosci, 2015, 7(9): 112.
|
6. |
Szczesny E, Basta-Kaim A, Slusarczyk J, et al. The impact of prenatal stress on insulin-like growth factor-1 and pro-inflammatory cytokine expression in the brains of adult male rats: the possible role of suppressors of cytokine signaling proteins. J Neuroimmunol, 2014, 276(1/2): 37-46.
|
7. |
Yen T E, Allen J C, Rivelli S K, et al. Association between serum IGF-I levels and postoperative delirium in elderly subjects undergoing elective knee arthroplasty. Sci Rep, 2016, 6: 20736.
|
8. |
Shen Huachun, Shao Yi, Chen Junping, et al. Insulin-like growth factor-1, a potential predicative biomarker for postoperative delirium among elderly patients with open abdominal surgery. Curr Pharm Des, 2016, 22(38): 5879-5883.
|
9. |
Chu Chesheng, Liang C K, Chou M Y, et al. Lack of association between pre-operative insulin-like growth factor-1 and the risk of post-operative delirium in elderly Chinese patients. Psychiatry Investig, 2016, 13(3): 327-332.
|
10. |
van Munster B C, Korevaar J C, Zwinderman A H, et al. The association between delirium and the apolipoprotein E epsilon 4 allele: new study results and a meta-analysis. Am J Geriatr Psychiatry, 2009, 17(10): 856-862.
|
11. |
Stoicea N, Mcvicker S, Quinones A, et al. Delirium-biomarkers and genetic variance. Front Pharmacol, 2014, 5: 75.
|
12. |
Ma Yunlong, Fan Rongli, Li M D. Meta-analysis reveals significant association of the 3’-UTR VNTR in SLC6A3 with alcohol dependence. Alcohol Clin Exp Res, 2016, 40(7): 1443-1453.
|
13. |
van Munster B C, Korse C M, de Rooij S E, et al. Markers of cerebral damage during delirium in elderly patients with hip fracture. BMC Neurol, 2009, 9: 21.
|
14. |
Watne L O, Hall R J, Molden E, et al. Anticholinergic activity in cerebrospinal fluid and serum in individuals with hip fracture with and without delirium. J Am Geriatr Soc, 2014, 62(1): 94-102.
|
15. |
Qiu Yimin, Huang Xiaojing, Huang Lina, et al. 5-HT(1A) receptor antagonist improves behavior performance of delirium rats through inhibiting PI3K/Akt/mTOR activation-induced NLRP3 activity. IUBMB Life, 2016, 68(4): 311-319.
|
16. |
Tomasi C D, Salluh J, Soares M, et al. Baseline acetylcholinesterase activity and serotonin plasma levels are not associated with delirium in critically ill patients. Rev Bras Ter Intensiva, 2015, 27(2): 170-177.
|
17. |
Egberts A, Fekkes D, Wijnbeld E H, et al. Disturbed serotonergic neurotransmission and oxidative stress in elderly patients with delirium. Dement Geriatr Cogn Dis Extra, 2016, 5(3): 450-458.
|
18. |
Balan S, Leibovitz A, Zila S O, et al. The relation between the clinical subtypes of delirium and the urinary level of 6-SMT. J Neuropsychiatry Clin Neurosci, 2003, 15(3): 363-366.
|
19. |
de Rooij S E, van Munster B C, Korevaar J C, et al. Cytokines and acute phase response in delirium. J Psychosom Res, 2007, 62(5): 521-525.
|
20. |
van den Boogaard M, Kox M, Quinn K L, et al. Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients. Crit Care, 2011, 15(6): R297.
|
21. |
Cape E, Hall R J, van Munster B C, et al. Cerebrospinal fluid markers of neuroinflammation in delirium: a role for interleukin-1β in delirium after hip fracture. J Psychosom Res, 2014, 77(3): 219-225.
|
22. |
Ritter C, Tomasi C D, Dal-Pizzol F, et al. Inflammation biomarkers and delirium in critically ill patients. Crit Care, 2014, 18(3): R106.
|
23. |
Baranyi A, Rothenhäusler H B. The impact of soluble interleukin-2 receptor as a biomarker of delirium. Psychosomatics, 2014, 55(1): 51-60.
|
24. |
Ritchie C W, Newman T H, Leurent B, et al. The association between C-reactive protein and delirium in 710 acute elderly hospital admissions. Int Psychogeriatr, 2014, 26(5): 717-724.
|
25. |
Zhang Zhongheng, Pan Lifei, Deng Hongsheng, et al. Prediction of delirium in critically ill patients with elevated C-reactive protein. J Crit Care, 2014, 29(1): 88-92.
|
26. |
Osse R J, Fekkes D, Tulen J H, et al. High preoperative plasma neopterin predicts delirium after cardiac surgery in older adults. J Am Geriatr Soc, 2012, 60(4): 661-668.
|
27. |
Egberts A, Wijnbeld E H, Fekkes D, et al. Neopterin: a potential biomarker for delirium in elderly patients. Dement Geriatr Cogn Disord, 2015, 39(1/2): 116-124.
|
28. |
Beaudeux J L, Laribi S. S100B protein serum level as a biomarker of minor head injury. Ann Biol Clin (Paris), 2013, 71(1): 71-78.
|
29. |
van Munster B C, Korevaar J C, Korse C M, et al. Serum S100B in elderly patients with and without delirium. Int J Geriatr Psychiatry, 2010, 25(3): 234-239.
|
30. |
Hall R J, Ferguson K J, Andrews M, et al. Delirium and cerebrospinal fluid S100B in hip fracture patients: a preliminary study. Am J Geriatr Psychiatry, 2013, 21(12): 1239-1243.
|
31. |
Harrington C R, Storey J M, Clunas S, et al. Cellular models of aggregation-dependent template-directed proteolysis to characterize Tau aggregation inhibitors for treatment of Alzheimer disease. J Biol Chem, 2015, 290(17): 10862-10875.
|
32. |
Wischik C M, Staff R T, Wischik D J, et al. Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer’s disease. J Alzheimers Dis, 2015, 44: 705-720.
|
33. |
Wang Junwen, Li Jun, Han Lin, et al. Serum τ protein as a potential biomarker in the assessment of traumatic brain injury. Exp Ther Med, 2016, 11(3): 1147-1151.
|